![](https://investorshub.advfn.com/uicon/545513.png?cb=1506116101)
Thursday, May 23, 2024 7:22:04 PM
They fact this article needs to be written could mean a legal battle is coming https://www.nature.com/articles/s41587-024-02208-0
Recent PRME News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:58:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:58:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:10:54 PM
- Prime Medicine to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/30/2024 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/21/2024 08:06:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:03:46 PM
- Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/13/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 12:22:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 12:05:55 PM
- Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 05/10/2024 12:00:00 PM
- Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD) • GlobeNewswire Inc. • 05/08/2024 12:00:00 PM
- Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference • GlobeNewswire Inc. • 05/01/2024 12:00:00 PM
- Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD) • GlobeNewswire Inc. • 04/29/2024 11:00:00 AM
- Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings • GlobeNewswire Inc. • 04/23/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/01/2024 01:09:57 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/01/2024 01:04:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 01:01:39 PM
- Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/01/2024 01:00:00 PM
- Prime Medicine to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:02:07 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 02/23/2024 02:31:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:38:59 PM
- Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 02/20/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 11:23:32 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM